XML 17 R6.htm IDEA: XBRL DOCUMENT v3.21.2
Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Common Stock [Member]
Additional Paid-in Capital [Member]
Treasury Stock [Member]
Retained Earnings [Member]
Accumulated Other Comprehensive Income (Loss) [Member]
Total
Balance at Dec. 31, 2019 $ 25 $ 5,037 $ (9,773) $ 62,211 $ (1,081) $ 56,419
Balance (in shares) at Dec. 31, 2019           9,022,187
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock-based compensation expense 0 228 0 0 0 $ 228
Issuance of restricted stock $ 0 0 0 0 0 0
Issuance of restricted stock (in shares) 20,804          
Net income (loss) $ 0 0 0 (1,738) 0 (1,738) [1]
Foreign currency translation adjustments, net of tax 0 0 0 0 (346) (346)
Balance at Mar. 31, 2020 25 5,265 (9,773) 60,473 (1,427) $ 54,563
Balance (in shares) at Mar. 31, 2020           9,042,991
Balance at Dec. 31, 2020 25 5,924 (9,773) 57,310 (1,292) $ 52,194
Balance (in shares) at Dec. 31, 2020           9,150,806
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock-based compensation expense 0 183 0 0 0 $ 183
Issuance of restricted stock $ 0 0 0 0 0 0
Issuance of restricted stock (in shares) 16,080          
Repurchase of common stock $ (1) (1,674)   0 0 (1,675)
Repurchase of common stock (in shares) (500,000)          
Net income (loss) $ 0 0 0 745 0 745
Foreign currency translation adjustments, net of tax 0 0 0 0 (33) (33)
Balance at Mar. 31, 2021 $ 24 $ 4,433 $ (9,773) $ 58,055 $ (1,325) $ 51,414
Balance (in shares) at Mar. 31, 2021           8,666,886
[1] For the three months ended March 31, 2020, there were 492 shares excluded from the diluted EPS calculation because the impact of their assumed vesting would be anti-dilutive due to a net loss in that period.